These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 25742094)

  • 1. Revealing molecular pathways for cancer cell fitness through a genetic screen of the cancer translatome.
    Kuzuoglu-Ozturk D; Hu Z; Rama M; Devericks E; Weiss J; Chiang GG; Worland ST; Brenner SE; Goodarzi H; Gilbert LA; Ruggero D
    Cell Rep; 2021 Jun; 35(13):109321. PubMed ID: 34192540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Akt/mTOR and MNK/eIF4E pathways rewire the prostate cancer translatome to secrete HGF, SPP1 and BGN and recruit suppressive myeloid cells.
    Brina D; Ponzoni A; Troiani M; Calì B; Pasquini E; Attanasio G; Mosole S; Mirenda M; D'Ambrosio M; Colucci M; Guccini I; Revandkar A; Alajati A; Tebaldi T; Donzel D; Lauria F; Parhizgari N; Valdata A; Maddalena M; Calcinotto A; Bolis M; Rinaldi A; Barry S; Rüschoff JH; Sabbadin M; Sumanasuriya S; Crespo M; Sharp A; Yuan W; Grinu M; Boyle A; Miller C; Trotman L; Delaleu N; Fassan M; Moch H; Viero G; de Bono J; Alimonti A
    Nat Cancer; 2023 Aug; 4(8):1102-1121. PubMed ID: 37460872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligustrazine monomer against cerebral ischemia/reperfusion injury.
    Gao HJ; Liu PF; Li PW; Huang ZY; Yu FB; Lei T; Chen Y; Cheng Y; Mu QC; Huang HY
    Neural Regen Res; 2015 May; 10(5):832-40. PubMed ID: 26109963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systems biology network-based discovery of a small molecule activator BL-AD008 targeting AMPK/ZIPK and inducing apoptosis in cervical cancer.
    Fu L; Zhang S; Zhang L; Tong X; Zhang J; Zhang Y; Ouyang L; Liu B; Huang J
    Oncotarget; 2015 Apr; 6(10):8071-88. PubMed ID: 25797270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of DNA methyltransferase as a novel therapeutic strategy to overcome acquired resistance to dual PI3K/mTOR inhibitors.
    Qian XJ; Li YT; Yu Y; Yang F; Deng R; Ji J; Jiao L; Li X; Wu RY; Chen WD; Feng GK; Zhu XF
    Oncotarget; 2015 Mar; 6(7):5134-46. PubMed ID: 25762617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translational control of chronic pain.
    Melemedjian OK; Khoutorsky A
    Prog Mol Biol Transl Sci; 2015; 131():185-213. PubMed ID: 25744674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the translation machinery in cancer.
    Bhat M; Robichaud N; Hulea L; Sonenberg N; Pelletier J; Topisirovic I
    Nat Rev Drug Discov; 2015 Apr; 14(4):261-78. PubMed ID: 25743081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative studies of mRNA recruitment to the eukaryotic ribosome.
    Fraser CS
    Biochimie; 2015 Jul; 114():58-71. PubMed ID: 25742741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel therapeutic strategy targeting the Hedgehog signalling and mTOR pathways in biliary tract cancer.
    Zuo M; Rashid A; Churi C; Vauthey JN; Chang P; Li Y; Hung MC; Li D; Javle M
    Br J Cancer; 2015 Mar; 112(6):1042-51. PubMed ID: 25742482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligustrazine inhibits the viability and motility of colon cancer cells.
    Chen X; Yang X; Mu J; Yue C
    Transl Cancer Res; 2020 May; 9(5):3203-3213. PubMed ID: 35117686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetramethylpyrazine: A Review of Its Antitumor Potential and Mechanisms.
    Yang S; Wu S; Dai W; Pang L; Xie Y; Ren T; Zhang X; Bi S; Zheng Y; Wang J; Sun Y; Zheng Z; Kong J
    Front Pharmacol; 2021; 12():764331. PubMed ID: 34975475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetramethylpyrazine inhibits proliferation of colon cancer cells
    Li H; Hou YX; Yang Y; He QQ; Gao TH; Zhao XF; Huo ZB; Chen SB; Liu DX
    World J Clin Cases; 2021 Jun; 9(18):4542-4552. PubMed ID: 34222421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Tetramethylpyrazine Derivative Statmp-151: A Novel Small Molecule Stat3 Inhibitor With Promising Activity Against Breast Cancer.
    Fan C; Wang Y; Huang H; Li W; Ma J; Yao D; Tang Z; Xue T; Ha L; Ren Y; Zhang Y; Wang Q; Xie Y; Luo Y; Tan R; Gu J
    Front Pharmacol; 2021; 12():651976. PubMed ID: 33967793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. eIF4E Phosphorylation in Prostate Cancer.
    D'Abronzo LS; Ghosh PM
    Neoplasia; 2018 Jun; 20(6):563-573. PubMed ID: 29730477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetramethylpyrazine inhibits prostate cancer progression by downregulation of forkhead box M1.
    Zhou Y; Ji Z; Yan W; Zhou Z; Li H; Xiao Y
    Oncol Rep; 2017 Aug; 38(2):837-842. PubMed ID: 28677763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of protein translation as a new treatment paradigm for prostate cancer.
    Ramamurthy VP; Ramalingam S; Kwegyir-Afful AK; Hussain A; Njar VCO
    Curr Opin Oncol; 2017 May; 29(3):210-220. PubMed ID: 28282343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms and Clinical Application of Tetramethylpyrazine (an Interesting Natural Compound Isolated from Ligusticum Wallichii): Current Status and Perspective.
    Zhao Y; Liu Y; Chen K
    Oxid Med Cell Longev; 2016; 2016():2124638. PubMed ID: 27668034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligustrazine Suppresses the Growth of HRPC Cells through the Inhibition of Cap- Dependent Translation Via Both the mTOR and the MEK/ERK Pathways.
    Han J; Song J; Li X; Zhu M; Guo W; Xing W; Zhao R; He X; Liu X; Wang S; Li Y; Huang H; Xu X
    Anticancer Agents Med Chem; 2015; 15(6):764-72. PubMed ID: 25742094
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.